Our strategy Our current strategic period started in 2021, setting out our vision and goals to achieve testing for healthy and safe lives.
ACT-Accelerator We co-convene the diagnostics pillar of this global collaboration to ensure access to COVID-19 tests for everyone, everywhere.
Self-testing Self-testing and self-sampling can support equitable access to testing to everyone, regardless of their location or social status.
100 Days Mission A plan for the world to be able to respond to and extinguish the global threat of the next Disease X within 100 days of WHO declaring a major outbreak or pandemic.
Diagnostics & IP Find out how intellectual property rights are protected in the diagnostics industry.
Press release FIND and Republic of Indonesia Ministry of Health ink partnership to drive access to essential diagnostic tests.
Press release Ayoade Alakija takes up FIND Chair as Soumya Swaminathan and Malebona Precious Matsoso also join FIND Board of Directors.
DxConnect Tools and resources provided under the DxConnect umbrella contain information managed and collated – but not owned – by FIND, as a service to the diagnostics community.
Data for decisions Diagnostics provide critical information for healthcare professionals, decision-makers, and people living with diseases and health conditions.
The diagnostic journey From R&D to implementation, the diagnostic value chain can be thought of as a journey of interconnected steps, or a "virtuous cycle".
Diagnostics Commission The Lancet Commission on diagnostics was published in 2021, putting forward recommendations to accelerate and transform access to diagnostics globally.
Toolkit A comprehensive manual for a next-generation sequencing with a focus on SARS-COV-2 USAID 10 Oct 2022
Toolkit Guidelines on testing methodologies. testing strategies, and setting up of SARS-CoV-2 testing laboratories USAID 01 Feb 2022